Current Therapeutic Research
Volume 62, Issue 4 , Pages 298-313, April 2001

Antihypertensive agents: mechanisms of action, safety profiles, and current uses in children

  • Douglas L. Blowey, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Douglas L. Blowey, MD Children's Mercy Hospital 2401 Gillham Road Kansas City, MO 64108

University of Missouri—Kansas City School of Medicine, Pediatric Nephrology and Clinical Pharmacology, Children's Mercy Hospital, Kansas City, Missouri U.S.A.

Abstract 

Background: Hypertension is uncommon in children, and relatively few children receive antihypertensive medications.

Objective: This article reviews the individual classes of antihypertensive medications as they are used in children, highlighting their proposed mechanisms of action, common adverse effects, and, when available, a summary of the published pediatric data.

Methods: Selected publications regarding the use and pharmacokinetics of antihypertensive agents in children were identified through a literature search using PubMed® (1970–1999).

Results: The amount of information regarding the effectiveness, safety, and adverse-effect profiles of antihypertensive agents in children is limited by the small number of patients involved and scientific study design.

Conclusions: Hypertension in children is uncommon when compared with its incidence in adults, but it frequently portends an underlying disease process and can be difficult to treat. Few antihypertensive agents have been tested in children, and treatment guidelines are often based on previous experience in a small number of patients. Safe and effective use of antihypertensive agents requires adequate knowledge of their pharmacologic properties, including metabolism, disposition, and effects in children of varying ages.

Keywords:  children, antihypertensives, hypertension, mechanism of action

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0011-393X(01)80014-X

doi:10.1016/S0011-393X(01)80014-X

Current Therapeutic Research
Volume 62, Issue 4 , Pages 298-313, April 2001